-transparent.png){kind=logo}
SK&F 93319 (icotidine), 2-[4-(3-methoxypyrid-2-yl)butylamino]-5-[(6-methylpyrid-3-yl )-methyl]- pyrimidin-4-one trihydrochloride, has been identified as a novel agent which combines into one molecule the ability to antagonize the actions of histamine at H1 and H2 receptors across a similar concentration or dose range. The degree of antagonism of vascular responses to histamine exceeds that possible with either an H1- or H2-receptor histamine antagonist alone. SK&F 93319 may have therapeutic utility in conditions requiring simultaneous antagonism of histamine at H1 and H2 receptors.
Related Publications
C R Ganellin, and
R C Blakemore, and
T H Brown, and
D G Cooper, and
G J Durant, and
C A Harvey, and
R J Ife, and
D A Owen, and
M E Parsons, and
A C Rasmussen
October 1984,
British journal of pharmacology,
C R Ganellin, and
R C Blakemore, and
T H Brown, and
D G Cooper, and
G J Durant, and
C A Harvey, and
R J Ife, and
D A Owen, and
M E Parsons, and
A C Rasmussen
November 1973,
Nature,
C R Ganellin, and
R C Blakemore, and
T H Brown, and
D G Cooper, and
G J Durant, and
C A Harvey, and
R J Ife, and
D A Owen, and
M E Parsons, and
A C Rasmussen
November 1988,
Allergie et immunologie,
C R Ganellin, and
R C Blakemore, and
T H Brown, and
D G Cooper, and
G J Durant, and
C A Harvey, and
R J Ife, and
D A Owen, and
M E Parsons, and
A C Rasmussen
June 1987,
Annals of the rheumatic diseases,
C R Ganellin, and
R C Blakemore, and
T H Brown, and
D G Cooper, and
G J Durant, and
C A Harvey, and
R J Ife, and
D A Owen, and
M E Parsons, and
A C Rasmussen
March 1975,
Nature,
C R Ganellin, and
R C Blakemore, and
T H Brown, and
D G Cooper, and
G J Durant, and
C A Harvey, and
R J Ife, and
D A Owen, and
M E Parsons, and
A C Rasmussen
January 1988,
Pharmacology,
C R Ganellin, and
R C Blakemore, and
T H Brown, and
D G Cooper, and
G J Durant, and
C A Harvey, and
R J Ife, and
D A Owen, and
M E Parsons, and
A C Rasmussen
January 1980,
General pharmacology,
C R Ganellin, and
R C Blakemore, and
T H Brown, and
D G Cooper, and
G J Durant, and
C A Harvey, and
R J Ife, and
D A Owen, and
M E Parsons, and
A C Rasmussen
April 1979,
Agents and actions,
C R Ganellin, and
R C Blakemore, and
T H Brown, and
D G Cooper, and
G J Durant, and
C A Harvey, and
R J Ife, and
D A Owen, and
M E Parsons, and
A C Rasmussen
January 1979,
Farmakologiia i toksikologiia,
C R Ganellin, and
R C Blakemore, and
T H Brown, and
D G Cooper, and
G J Durant, and
C A Harvey, and
R J Ife, and
D A Owen, and
M E Parsons, and
A C Rasmussen
May 1980,
British journal of pharmacology,
